@npr.org on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

NPR

npr.org

did:plc:ln72v57ivz2g46uqf4xxqiuh

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. n.pr/4sR4fyc https://n.pr/4sR4fyc

2026-04-23T21:34:18.859Z